Technical Articles

Glypican-3 (GPC3), as a hepatocellular carcinoma-specific tumor antigen, has become a crucial target in the field of precision medicine. By combining the targeting specificity of GPC3 with the superior fluorescence performance of Alexa Fluor 647, the developed fluorescently labeled chimeric protein provides a highly sensitive and specific research tool for tumor marker detection, cell phenotype identification, and targeted drug development.